Literature DB >> 8946277

IL-10 suppresses cell surface CD23/Fc epsilon RII expression, not by enhancing soluble CD23 release, but by reducing CD23 mRNA expression in human monocytes.

A Morinobu1, S Kumagai, H Yanagida, H Ota, H Ishida, M Matsui, J Yodoi, K Nakao.   

Abstract

To examine a possible involvement of interleukin-10 (IL-10) in CD23/Fc epsilon RII expression in human monocytes, effects of IL-10 on the cell surface CD23 expression, soluble CD23 (sCD23) release, and CD23 type b mRNA expression were investigated. IL-10 suppressed IL-4-induced surface CD23 expression on monocytes in a dose-dependent manner, and this effect was completely neutralized by anti-IL-10 antibody. The suppressive effect of IL-10 on surface CD23 expression was not due to enhancement of sCD23 release from the cell surface because no increase in sCD23 in culture supernatant was detected after incubation with IL-10. Instead, the effect of IL-10 seemed to be exerted at the transcriptional level since IL-4-induced expression of CD23 type b mRNA was significantly reduced when IL-10 was present. Although IL-4 induced surface CD23 expression on both monocytes and B cells, the suppressive effect of IL-10 was observed only on monocytes, which underscores different regulatory mechanisms for CD23 expression between the two cell types.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8946277     DOI: 10.1007/bf01541668

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

1.  IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes.

Authors:  L Borish; J J Mascali; L J Rosenwasser
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

2.  Detection of circulating Fc epsilon R2/CD23+ monocytes in patients with rheumatic diseases.

Authors:  H Becker; P Potyka; C Weber; K Federlin
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 3.  Regulation of the expression of Fc epsilon R2 and IgE-BF.

Authors:  J Yodoi; M Hosoda; M Takami; T Kawabe
Journal:  Chem Immunol       Date:  1989

4.  Regulation of Fc epsilon R2/CD23 gene expression by cytokines and specific ligands (IgE and anti-Fc epsilon R2 monoclonal antibody). Variable regulation depending on the cell types.

Authors:  T Kawabe; M Takami; M Hosoda; Y Maeda; S Sato; M Mayumi; H Mikawa; K Arai; J Yodoi
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

5.  CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18.

Authors:  S Lecoanet-Henchoz; J F Gauchat; J P Aubry; P Graber; P Life; N Paul-Eugene; B Ferrua; A L Corbi; B Dugas; C Plater-Zyberk
Journal:  Immunity       Date:  1995-07       Impact factor: 31.745

6.  Regulation of human monocyte cell-surface and soluble CD23 (Fc epsilon RII) by granulocyte-macrophage colony-stimulating factor and IL-3.

Authors:  M R Alderson; T W Tough; S F Ziegler; R J Armitage
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

7.  Soluble CD23 potentiates interleukin-1-induced secretion of interleukin-6 and interleukin-1 receptor antagonist by human monocytes.

Authors:  A Herbelin; S Elhadad; F Ouaaz; D de Groote; B Descamps-Latscha
Journal:  Eur J Immunol       Date:  1994-08       Impact factor: 5.532

8.  Ligation of CD23 triggers cAMP generation and release of inflammatory mediators in human monocytes.

Authors:  N Paul-Eugene; J P Kolb; A Abadie; J Gordon; G Delespesse; M Sarfati; J M Mencia-Huerta; P Braquet; B Dugas
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

9.  Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo.

Authors:  C Plater-Zyberk; J Y Bonnefoy
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440

10.  Expression of the Fc-receptor for IgE (Fc epsilon RII, CD23) on alveolar macrophages in extrinsic allergic alveolitis.

Authors:  A Pforte; G Breyer; J C Prinz; P Gais; G Burger; K Häussinger; E P Rieber; E Held; H W Ziegler-Heitbrock
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

View more
  1 in total

1.  Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA).

Authors:  C Ribbens; V Bonnet; M J Kaiser; B Andre; O Kaye; N Franchimont; D de Groote; Y Beguin; M G Malaise
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.